Mohamed Seleem

West Lafayette, IN, United States of America

Mohamed Seleem

This inventor holds 22 USPTO granted patents and 8 published patent applications, primarily in Antimicrobial Agents. Top assignees: Purdue Research Foundation, Other. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mohamed Seleem. Retrieved from https://idiyas.com/inventor/mohamed-seleem

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22 

% Patents Active = 90.9

Average Co-Inventor Count = 2.9

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:

goldMedal20 out of 2,785 
 
Purdue Research Foundation
 patents
silverMedal1 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 2016-2026

Loading Chart...
Areas of Expertise:
Antibiotic Susceptibility
Antimicrobial Compounds
Benzamide Agents
Carbonic Anhydrase Inhibitors
Cell-Penetrating Peptides
Aryl Isonitriles
Phenylthiazoles
Lactones
Cleavable Conjugates
Broad-Spectrum Antifungals
Multidrug Resistance
22 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Mohamed Seleem in Pharmaceutical Patents

Introduction

Mohamed Seleem, based in West Lafayette, IN, has made significant strides in the field of pharmaceuticals, reflected in his impressive portfolio of 19 patents. His innovations are primarily focused on developing new antibiotics and treatment methods for various infections, showcasing a strong commitment to advancing healthcare.

Latest Patents

Among his latest innovations is the patent for Diiodohydroxyquinoline for the treatment of Clostridium difficile infection. This method involves administering a therapeutically effective amount of diiodohydroxyquinoline, with or without one or more anti-infective agents, to treat the infection effectively. Another recent patent revolves around Benzamide antibacterial agents, which introduces new compounds designed as antibiotics to address infections caused by methicillin-resistant strains and other serious bacterial threats. These pharmaceutical compositions and treatment methods are crucial in combating antibiotic resistance and improving patient outcomes.

Career Highlights

Throughout his career, Mohamed has contributed significantly to the pharmaceutical landscape while working with notable institutions such as the University of Texas System. His research has not only led to numerous patents but also fostered a greater understanding of antibiotic resistance and treatment methodologies.

Collaborations

Mohamed has collaborated with esteemed colleagues such as Mingji Dai and Haroon Taj Mohammad. These partnerships have been vital in enhancing the development of his innovations, ensuring a diverse range of insights and expertise are integrated into his work, leading to better solutions in treating infections.

Conclusion

In conclusion, Mohamed Seleem stands out as a prolific inventor whose contributions to pharmaceutical patents reflect a profound impact on public health. His ongoing research and collaborative efforts continue to pave the way for advancements in medical treatments, particularly in combating challenging infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…